Fundraising FoxRemiges Ventures, Inc. — 2020 Investments
3 investments dated 2020 · listed companies and verified rows first · show all
Cyrano Therapeutics is a clinical-stage regenerative medicine company developing CYR-064, a nasal therapy for post-viral smell loss (hyposmia) and associated loss of taste.
BiotechDigital HealthHealthtechMedical DevicesDelray Beach, US
Rick Geoffrion(Founder, President and CEO & Board Member)inRichard Geoffrion(Executive Officer, Director)Robert Henkin(Director)
BoardGerry Brunk(Director)inTakahide Koda(Director)
Co-investorsLumira VenturesDeepWork CapitalFlorida Opportunity Fund
LUCA Science develops mitochondrial therapies that supply functional, storable mitochondria to damaged or dysfunctional cells and tissues to restore cellular energy production, targeting conditions such as ischemia-reperfusion injuries including cerebral and myocardial infarction.
BiotechDeep TechHealthtechLongevity
Co-investorsAsahi Kasei Corporate Venture CapitalFast Track Initiative4BIO CapitalAstellas Venture Management LLCAxil CapitalDCI Partners Co. Ltd.
Co-investorsSR One Capital ManagementVivo Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.